The ASCENT (Adherence Support Coalition to End TB) project (July 2019 – ongoing) builds on existing evidence, innovations in adherence technology and growing global momentum to implement integrated DAT interventions in five key countries (Ethiopia, the Philippines, South Africa, Tanzania, and Ukraine) for all types of TB (DS-TB, DR-TB, LTBI).

Comprised of four key outputs, the ASCENT project will operationalize a DAT intervention in diverse geographic, cultural, and infrastructural settings (Output 1), generate evidence via a shared evaluation framework for optimal use and scale (Output 2), establish a global market for optimized products, price and supply chain models of DAT (Output 3), and engage with key global and in-country stakeholders to prepare for scale-up of the DAT intervention (Output 4).

With its strong consortium of partners (KNCV Tuberculosis Foundation, The Aurum Institute, London School of Hygiene & Tropical Medicine and PATH) and partnership with the governments of the implementing countries, the ASCENT project will contribute to the adoption and uptake of digital adherence technologies. The ASCENT project is made possible thanks to Unitaid’s funding and support.

Countries: Ethiopia, Tanzania, the Philippines, Ukraine and South Africa

KNCV has been fighting TB since its establishment in 1903. Over the past 120 years, the organization has acquired indispensable knowledge and experience in the field of effective TB prevention and care, resulting in pre-elimination in the Netherlands and significant contributions to global evidence generation, policy development and TB program implementation worldwide.

Our experts
KNCV governance framework and integrity
Our patroness
Partner with us


De versie van de browser die je gebruikt is verouderd en wordt niet ondersteund.
Upgrade je browser om de website optimaal te gebruiken.